Literature DB >> 21841515

Should the management of isolated traumatic subarachnoid hemorrhage differ from concussion in the setting of mild traumatic brain injury?

A Stewart Levy1, Alessandro Orlando, Allison P Hawkes, Kristin Salottolo, Charles W Mains, David Bar-Or.   

Abstract

BACKGROUND: In the setting of mild traumatic brain injury (TBI), the clinical significance of a traumatic subarachnoid hemorrhage (tSAH) has not been sufficiently studied. We examined the impact of an isolated tSAH on patient outcomes in the mild TBI population.
METHODS: We retrospectively identified all mild TBI patients (Glasgow Coma Scale score ≥13) who presented to a Level I trauma center over a 10-year period. We compared isolated tSAH patients with isolated concussion patients. χ(2) and logistic regression analyses were used to compare intensive care unit (ICU) admission, ICU length of stay (LOS), hospital LOS, progression of tSAH, in-hospital mortality, and disposition to rehabilitation.
RESULTS: There were 1,144 concussion and 117 tSAH patients included in our study. After adjustment, tSAH patients had increased odds of admission to the ICU (odds ratio, [OR] = 8.87; p < 0.0001), yet their ICU LOS was significantly shorter (OR = 0.29; p = 0.01). The overall hospital LOS and mortality rate were not significantly different between the TBI groups. When stratified by age, only the 40-year to 69-year-old tSAH patients had significantly increased adjusted odds of disposition to rehabilitation compared with concussion patients, independent of ICU admission (OR = 7.96; p = 0.004). None of the patients required any neurosurgical interventions.
CONCLUSIONS: We encourage healthcare facilities to consider revising or creating ICU admission criteria for the mild TBI population to help optimize the utilization of their ICUs. We believe clinicians should place more emphasis on variables such as age, comorbidities, and neurologic condition rather than the presence of a small volume of blood in the subarachnoid space when admitting mild isolated TBI patients to the ICU.

Entities:  

Mesh:

Year:  2011        PMID: 21841515     DOI: 10.1097/TA.0b013e31822067fc

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

1.  Does isolated traumatic subarachnoid hemorrhage merit a lower intensity level of observation than other traumatic brain injury?

Authors:  Herb A Phelan; Adam A Richter; William W Scott; Jeffrey H Pruitt; Christopher J Madden; Kim L Rickert; Steven E Wolf
Journal:  J Neurotrauma       Date:  2014-08-27       Impact factor: 5.269

2.  Intensive Care Unit Admission Patterns for Mild Traumatic Brain Injury in the USA.

Authors:  Robert H Bonow; Alex Quistberg; Frederick P Rivara; Monica S Vavilala
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

3.  Association Between Intensive Care Unit Admission Practices and Outcomes in Patients with Isolated Traumatic Subarachnoid Hemorrhage: A Nationwide Inpatient Database Analysis in Japan.

Authors:  Keita Shibahashi; Hiroyuki Ohbe; Hideo Yasunaga
Journal:  Neurocrit Care       Date:  2022-05-23       Impact factor: 3.532

4.  The Risk of Deterioration in GCS13-15 Patients with Traumatic Brain Injury Identified by Computed Tomography Imaging: A Systematic Review and Meta-Analysis.

Authors:  Carl Marincowitz; Fiona E Lecky; William Townend; Aditya Borakati; Andrea Fabbri; Trevor A Sheldon
Journal:  J Neurotrauma       Date:  2018-01-11       Impact factor: 5.269

5.  Traumatic Subarachnoid Hemorrhage Resulting from Posterior Communicating Artery Rupture.

Authors:  Jiha Kim; Seung Jin Lee
Journal:  Int Med Case Rep J       Date:  2020-06-26

6.  Rapid Discharge After Interfacility Transfer for Mild Traumatic Intracranial Hemorrhage: Frequency and Associated Factors.

Authors:  Pierre Borczuk; Jonathan Van Ornam; Brian J Yun; Joshua Penn; Peter Pruitt
Journal:  West J Emerg Med       Date:  2019-02-11

Review 7.  Traumatic Subarachnoid Hemorrhage: A Scoping Review.

Authors:  Dylan P Griswold; Laura Fernandez; Andres M Rubiano
Journal:  J Neurotrauma       Date:  2021-04-22       Impact factor: 5.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.